Dermatology

According to a claims analysis, sunburn was also commonly diagnosed in female and young patients.

The prevalence of striae distensae was notably higher in psoriasis than atopic dermatitis.

Brett King, MD, PhD, encourages dermatologists to wait for more clinical data before making any assumptions on the drug class' safety and selectivity.

Brett King, MD, PhD, compares the efficacy of JAKs with biologics in the atopic dermatitis setting.

Experts in dermatology discuss the clinical presentation of atopic dermatitis, common comorbidities associated with the disease, and its impact on patient quality of life.

Margaret Bobonich, DNP, FNP-C, DCNP, FAANP, and Douglas DiRuggiero, DMSc, PA-C, provide an overview of atopic dermatitis including prevalence, age of onset, and diagnosis.

Brett King, MD, PhD, provides an overview of JAK inhibitors and their interaction with the JAK-STAT pathway.

Studies are needed to determine the best treatment regimen for these patients.

Treatment was associated with reductions in IGA scores as well as inflammatory and non-inflammatory lesion counts.

The selective topical PDE4 inhibitor demonstrated rapid improvements in IGA and EASI scores and high tolerability in pediatric populations.

On the latest Derm Discussions, Brett King, MD, PhD, joins Brad Glick, DO, to discuss the potential of the JAK inhibitor class for dermatology.

Males and patients with higher disease severity were more likely to attend program sessions.

More research is needed to understand the pathogenesis underlying this association.

The FDA will also not meet the PDUFA date for tofacitinib for the treatment of active ankylosing spondylitis.

Gastrointestinal infections were the most common serious infections associated with biologics, according to a cohort analysis.

Upadacitinib has shown promising results for a variety of diseases such as severe atopic dermatitis and psoriatic arthritis, but its future remains uncertain.

Less than half of affected patients (42.86%) indicated previous history of conjunctivitis prior to initiating dupilumab treatment.

Research on the effect of methotrexate and other immunosuppressants in regard to the COVID-19 vaccine are encouraging yet unfinished.

Despite a global decrease in asthma deaths, researchers say the disease is particularly threatening to patients with atopic dermatitis.

Investigators show that both terms tend to be used in different contexts within the biomedical literature.

Misha Rosenbach, MD, mentions various ways dermatologists (and the population at large) can be more mindful of their impact on the environment

Researchers found that different pets elicit different allergy responses in child participants.

Patients on placebo with a history of systemic non-steroidal immunosuppressants generally fared worse than their treatment-naïve counterparts.

Among 49,197 vaccinated employees at Mass General Brigham, 776 self-reported cutaneous reactions following the first dose.

These results highlight the importance of interventions to address modifiable behaviors and risk factors for these patients.